A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer von Page, David B, Pucilowska, Joanna, Sanchez, Katherine G, Conrad, Valerie K, Conlin, Alison K, Acheson, Anupama K, Perlewitz, Kelly S, Imatani, James H, Aliabadi-Wahle, Shaghayegh, Moxon, Nicole, Mellinger, Staci L, Seino, Amanda Y, Martel, Martiza, Wu, Yaping, Sun, Zhaoyu, Redmond, William L, Rajamanickam, Venkatesh, Waddell, Dottie, Laxague, Deborah, Shah, Monil, Chang, Shu-Ching, Urba, Walter J

Volltext

Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates von MEYER, Janelle M, PERLEWITZ, Kelly S, MORI, Motomi, HOLTORF, Megan L, AFZAL, Aneela, WOODWARD, William J, RODLER, Eve T, JONES, Robin L, WEI HUANG, RYAN, Christopher W, HAYDEN, James B, DOUNG, Yee-Cheen, HUNG, Arthur Y, VETTO, John T, POMMIER, Rodney F, MANSOOR, Atiya, BECKETT, Brooke R, TUDORICA, Alina

Volltext

Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas von Lu, Eric, Perlewitz, Kelly S., Hayden, James B., Hung, Arthur Y., Doung, Yee-Cheen, Davis, Lara E., Mansoor, Atiya, Vetto, John T., Billingsley, Kevin G., Kaempf, Andy, Park, Byung, Ryan, Christopher W.

Volltext

385P A phase II study of nivolumab, ipilimumab plus bicalutamide in metastatic breast cancer von Page, D.B., Kaur, L., Hong, E.C.C., Su, A., Moxon, N., Mellinger, S., Kelly, T., Kelley, A., Fredrich, N., Seino, A., Liberatore, G., Conlin, A.K., Topp, Z., Perlewitz, K., Stanton, S., Wu, Y., Traina, T.A., Gucalp, A.

Volltext

Abstract OT1-18-03: The neoIRX trial:locoregional cytokine therapy to promote immunologic priming and enhanced response to neoadjuvant pembrolizumab plus chemotherapy in triple neg... von Sanchez, Katherine, Conlin, Alison, Peddi, Parvin, Stanton, Sasha, Ruzich, Janet, Perlewitz, Kelly, Wu, Yaping, Moxon, Nicole, Mellinger, Staci, Sun, Zhaoyu, Redmond, William, Page, David B

Volltext

Phase (Ph) I/II study of pembrolizumab (P) with gemcitabine (G) in patients (pts) with previously-treated advanced (Adv) non-small cell lung cancer (NSCLC) von Sanborn, Rachel E., Duffy, Regan M., Fisher, Brenda K, Perlewitz, Kelly Shea, Wallen, Herschel D., Li, Rui, Redmond, William L, Koguchi, Yoshinobu, Fox, Bernard A.

Volltext

A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results von Sanborn, Rachel E., Duffy, Regan M., Fisher, Brenda K, Perlewitz, Kelly Shea, Redmond, William L, Koguchi, Yoshinobu, Fox, Bernard A.

Volltext

Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) von Page, David B., Kim, Isaac K, Sanchez, Katherine, Moxon, Nicole, Mellinger, Staci L., Conlin, Alison Katherine, Acheson, Anupama Kurup, Perlewitz, Kelly Shea, Lewis, Stacy K., Kemmer, Kathleen A., Mitri, Zahi Ibrahim, Basho, Reva K, Riffle, Emily, Ahn, Jenny, Pucilowska, Joanna, Martel, Maritza, Urba, Walter John, McArthur, Heather L.

Volltext

Phase I study of neoadjuvant chemoradiation (CRT) plus sorafenib (S) for high-risk extremity soft tissue sarcomas (STS) von Meyer, Janelle Marie, Perlewitz, Kelly Shea, Hayden, James B., Hung, Arthur, Doung, Yee-Cheen, Mansoor, Atiya, Beckett, Brooke, Holtorf, Megan L., Woodward, William J., Rodler, Eve T., Jones, Robin Lewis, Huang, Wei, Ryan, Christopher W.

Volltext